Ranitidine and Fosaprepitant drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranitidine (ranitidine) and Fosaprepitant (fosaprepitant). Common drug interactions include infusion site infection among females and pancreatitis acute among males.

The phase IV clinical study analyzes what interactions people have when they take Ranitidine and Fosaprepitant. It is created by eHealthMe based on reports of 52 people who take the same drugs from the FDA, and is updated regularly.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.

What is Fosaprepitant?

Fosaprepitant has active ingredients of fosaprepitant. eHealthMe is studying from 1,178 Fosaprepitant users. Check the latest studies of Fosaprepitant.

On Jul, 03, 2026

52 people who take Ranitidine and Fosaprepitant together, and have interactions are studied.

Ranitidine and Fosaprepitant drug interactions.

What are the common drug interactions of Ranitidine and Fosaprepitant, by gender? *:

female:

Infusion site infection
Fall
Ocular myasthenia (a disease of the neuromuscular junction resulting in hallmark variability in muscle weakness and fatigability)
Myasthenia gravis (a chronic condition that causes muscles to tire and weaken easily)
Bacteraemia (presence of bacteria in the blood)
Encephalopathy (functioning of the brain is affected by some agent or condition)
Transaminases increased
Cardiac failure congestive
Mitral valve incompetence (inefficient heart valve)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)

male:

Pancreatitis acute (sudden inflammation of pancreas)
Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)
Febrile neutropenia (fever with reduced white blood cells)
Platelet count decreased
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Septic shock (shock due to blood infection)
Thrombocytopenia (decrease of platelets in blood)
Wound complication
Chest pain
Respiratory failure (inadequate gas exchange by the respiratory system)

What are the common drug interactions of Ranitidine and Fosaprepitant, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Pancreatitis acute (sudden inflammation of pancreas)

20-29:

Hepatobiliary disease (diseases affect the liver and/or biliary tract)

30-39:

n/a

40-49:

Transaminases increased
Febrile neutropenia (fever with reduced white blood cells)

50-59:

Wound complication
Bacteraemia (presence of bacteria in the blood)
Encephalopathy (functioning of the brain is affected by some agent or condition)
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Colitis (inflammation of colon)
Enteritis (inflammation of the small intestine)
Intestinal perforation (complete penetration of the wall of the intestine)
Sepsis (a severe blood infection that can lead to organ failure and death)

60+:

Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)
Thrombocytopenia (decrease of platelets in blood)
Alopecia (absence of hair from areas of the body)
Febrile neutropenia (fever with reduced white blood cells)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Nausea (feeling of having an urge to vomit)
Platelet count decreased
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Renal failure (kidney dysfunction)
Septic shock (shock due to blood infection)

What are the existing conditions these people have? *

Pain: 19 people, 36.54%
Nausea (feeling of having an urge to vomit): 18 people, 34.62%
Constipation: 14 people, 26.92%
Ovarian Cancer (cancer of ovary): 12 people, 23.08%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 9 people, 17.31%
Stress And Anxiety: 8 people, 15.38%
Device Related Infection: 8 people, 15.38%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 8 people, 15.38%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 8 people, 15.38%
High Blood Pressure: 7 people, 13.46%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine and Fosaprepitant?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously